# Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis

> **NCT00728598** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy
- Angiogenesis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00728598
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 1998-12
- **Final completion:** 1998-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728598, "Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00728598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*